Clinical Trials Logo

Lichen Sclerosus Et Atrophicus clinical trials

View clinical trials related to Lichen Sclerosus Et Atrophicus.

Filter by:

NCT ID: NCT03561428 Recruiting - Lichen Sclerosus Clinical Trials

Biomarkers of Lichen Sclerosus

Start date: November 27, 2017
Phase:
Study type: Observational

Lichen sclerosus (LS) is a skin condition of the external genitals (vulva) of women. LS causes vulvar itching, pain, and burning. In addition, LS causes scarring of the vulva which may cause significant lack of sexual pleasure or pain. Lastly, 4-6% of women with LS will develop vulvar cancer. The purpose of this study is to learn the gene expression file changes in skins affected by LS as compared to normal skins in order to discover the mechanism of the LS, and further to develop effective drugs to treat the condition.

NCT ID: NCT03525522 Active, not recruiting - Lichen Sclerosus Clinical Trials

Nd:Yttrium Aluminum Garnet Laser Treatment for Lichen Sclerosus

Start date: January 28, 2016
Phase: N/A
Study type: Interventional

This study evaluates the efficacy of Nd:Yttrium Aluminum Garnet Laser (Nd:YAG) Treatment of Lichen sclerosus in comparison with topical corticosteroid treatment. Half of participants will receive laser treatment and the other half corticosteroid treatment and the results will be followed for 6 months.

NCT ID: NCT03419377 Completed - Lichen Sclerosus Clinical Trials

Lichen Sclerosus - the Influence on Quality of Life

Start date: January 4, 2018
Phase: N/A
Study type: Interventional

A randomised controlled trial of Lichen Sclerosus in a period of six months measuring Quality of Life and sexuality among women with Lichen Sclerosus.

NCT ID: NCT03063684 Completed - Vaginal Atrophy Clinical Trials

Fractional / Pixel CO2 Laser Treatment of Vulvar Atrophy and Lichen Sclerosus

Start date: September 1, 2017
Phase: N/A
Study type: Interventional

The study will examine the effects of fractional/pixel CO2 laser treatment in vaginal atrophy and in vulvar lichen sclerosus by means of histological and immuno-histochemical characterization of the epithelial layers and markers of tissue aging. The tissue characterization will be performed by biopsies of the vaginal or vulvar tissue at three different points of time: prior to treatment, two weeks after the third and last treatment, and one year after the last treatment.

NCT ID: NCT03045172 Completed - Clinical trials for Lichen Sclerosus of Vulva

Platelet Rich Plasma (PRP) for Vulvar Lichen Sclerosus

Start date: November 2016
Phase: N/A
Study type: Interventional

Lichen sclerosus (LS) is a skin condition of the external genitals (vulva) of women. LS causes vulvar itching, pain, and burning. In addition, LS causes scarring of the vulva which may cause significant sexual dysfunction or pain. Lastly, 4-6% of women with LS will develop vulvar cancer. The current "gold standard" treatment for lichen sclerosus is potent steroids creams. When used correctly, steroid creams help to decrease the symptoms of itching and burning and can prevent further vulvar scarring. In addition, proper treatment reverses the underlying inflammation of LS, and may lower the risk of getting cancer. While useful, steroid creams may have serious side effects that include thinning of the skin, fungal infections, and lowering the immune system. Platelet-rich plasma (PRP) is a platelet concentrate that helps to speed up tissue healing, without serious side effects, in a very wide range of medical conditions such as diabetic foot ulcers, muscle injury, tendon injury, and in a variety of cosmetic procedures. The PRP works because of its high level of proteins that help with wound healing. It is also apparent from the majority of published studies that PRP therapy has minimal risk of scar tissue formation or significant bad side effects. Recently, there was an exploratory study of twelve subjects that used PRP for the study treatment of lichen sclerosus. While this study showed good success, the study was limited because of its small size and lack of placebo (a drug or study treatment that contains no active ingredient) control.

NCT ID: NCT02881229 Terminated - Vulvodynia Clinical Trials

Vulvar Mucosal Specialty Clinic Chart Review

Start date: April 2016
Phase:
Study type: Observational

This study aims to develop a clinical database of patients presenting with vulvar complaints in order to comprehensively assess the presentation and current trends in management of vulvar disease.

NCT ID: NCT02880904 Terminated - Lichen Sclerosus Clinical Trials

Vulvar Scarring Grading Scale for Lichen Sclerosus

Start date: March 2016
Phase:
Study type: Observational

The study aims to validate a vulvar scarring grading scale for lichen sclerosus (LS).

NCT ID: NCT02854995 Completed - Clinical trials for Balanitis Xerotica Obliterans (BXO)

Circumcision Versus Preputioplasty for BXO in Children

BXO
Start date: October 1, 2016
Phase: N/A
Study type: Interventional

Traditionally, BXO is managed with circumcision (surgical removal of the foreskin) and this approach has long been held as the 'gold standard. Whilst this may be curative in many cases, it has been shown that 20% of boys require a further operative procedure on their penis to widen the urethral opening (to treat meatal stenosis) An alternative to circumcision was proposed: a preputioplasty (surgery to widen the opening of the foreskin) was combined with injection of steroids into the affected foreskin. Subsequently, the same group compared the outcomes of this technique with circumcision, and reported circumcision was successfully avoided in 92% of the preputioplasty group. In addition, the rate of meatal stenosis (narrowing of the urethral opening requiring surgery) was significantly lower (6% vs 19%, P = .034 ). Preputioplasty may therefore: (i) offer protection against meatal stenosis and reduce the requirement for further surgery; and (ii) offer the benefit of retaining the foreskin, the function of which, while debated, likely includes sexual function. In view of these potential benefits, authors have called for a randomised trial to compare circumcision to preputioplasty and injection of steroids.

NCT ID: NCT02794363 Completed - Lichen Sclerosus Clinical Trials

Platelet Rich Plasma Injections for Vulvar Lichen Sclerosus

Start date: May 2014
Phase: N/A
Study type: Interventional

15 patients with biopsy proven active vulvar lichen sclerosus will be recruited by a clinic specializing in vulvar disorders. This study consists of a 2 week screening period and a 12-week treatment period. Participants will receive two separate treatments of autologous platelet rich plasma separated by 6 weeks. A repeat biopsy will be performed 6 weeks after the second autologous platelet rich plasma injection

NCT ID: NCT02732145 Completed - Vulvodynia Clinical Trials

Diagnostic Accuracy of "Three Rings Vulvoscopy" for Detection of Vulvar Dermatosis

DATRIV
Start date: December 2011
Phase: N/A
Study type: Interventional

The objective of the study was to determine sensitivity, specificity and diagnostic accuracy of "Three Rings Vulvoscopy" for detection of vulvar dermatosis using histopathology as the reference standard.